​

InspireMD (NSPR) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

NSPR Stock Forecast

InspireMD (NSPR) stock forecast, based on 7 Wall Street analysts, predicts a 12-month average price target of $5.50, with a high of $6.00 and a low of $5.00. This represents a 203.87% increase from the last price of $1.81.

$1 $2 $3 $4 $5 $6 High: $6 Avg: $5.5 Low: $5 Last Closed Price: $1.81

NSPR Stock Rating

InspireMD stock's rating consensus is Buy, based on 7 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 6 Buy (85.71%), 1 Hold (14.29%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 7 0 1 6 Strong Sell Sell Hold Buy Strong Buy

NSPR Price Target Upside V Benchmarks

TypeNameUpside
StockInspireMD203.87%
SectorHealthcare Stocks 15.45%
IndustryMedical Device Stocks32.29%

Price Target Trends

1M3M12M
# Anlaysts122
Avg Price Target$5.00$5.50$5.50
Last Closing Price$1.81$1.81$1.81
Upside/Downside176.24%203.87%203.87%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Mar, 2621---3
Feb, 2621---3
Jan, 2611---2
Dec, 2511---2
Nov, 2511---2
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Feb 24, 2026Frank TakkinenLoop Capital Markets$5.00$1.82174.73%176.24%
Feb 02, 2026Maxim Group$6.00$1.68257.14%231.49%
Dec 11, 2024Frank TakkinenLake Street$5.00$3.1757.73%176.24%
Sep 17, 2024Adam MaederPiper Sandler$4.50$2.6172.41%148.62%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Feb 24, 2026Lake StreetBuyBuyhold
Dec 11, 2024Lake StreetBuyinitialise
Sep 17, 2024Piper SandlerOverweightOverweighthold

Financial Forecast

EPS Forecast

Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-2.03$-2.35$-0.82$-0.76$-0.76--
Avg Forecast$-2.30$-2.59$-0.87$-0.78$-1.38$-1.25$-0.37
High Forecast$-2.30$-2.56$-0.86$-0.77$-1.36$-1.23$-0.36
Low Forecast$-2.30$-2.62$-0.88$-0.79$-1.40$-1.26$-0.38
Surprise %-11.74%-9.27%-5.75%-2.56%-44.93%--

Revenue Forecast

$0 $10M $20M $30M $40M $50M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$4.50M$5.17M$6.21M$7.01M$8.98M--
Avg Forecast$4.50M$5.00M$6.10M$6.90M$10.32M$26.78M$48.41M
High Forecast$4.50M$5.04M$6.16M$6.97M$10.43M$27.07M$48.92M
Low Forecast$4.50M$4.96M$6.03M$6.82M$10.21M$26.50M$47.90M
Surprise %-0.11%3.42%1.76%1.63%-12.99%--

Net Income Forecast

$-65M $-51M $-37M $-23M $-9M $5M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-14.92M$-18.49M$-19.92M$-32.01M$891.00K--
Avg Forecast$-55.82M$-62.85M$-21.11M$-18.93M$-33.20M$-30.21M$-8.98M
High Forecast$-55.82M$-62.20M$-20.82M$-18.67M$-33.03M$-29.80M$-8.86M
Low Forecast$-55.82M$-63.51M$-21.40M$-19.19M$-33.95M$-30.63M$-9.10M
Surprise %-73.27%-70.58%-5.67%69.08%-102.68%--

NSPR Forecast FAQ

Is InspireMD stock a buy?

InspireMD stock has a consensus rating of Buy, based on 7 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 6 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that InspireMD is a favorable investment for most analysts.

What is InspireMD's price target?

InspireMD's price target, set by 7 Wall Street analysts, averages $5.5 over the next 12 months. The price target range spans from $5 at the low end to $6 at the high end, suggesting a potential 203.87% change from the previous closing price of $1.81.

How does InspireMD stock forecast compare to its benchmarks?

InspireMD's stock forecast shows a 203.87% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical device stocks industry (32.29%).

What is the breakdown of analyst ratings for InspireMD over the past three months?

  • March 2026: 66.67% Strong Buy, 33.33% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • February 2026: 66.67% Strong Buy, 33.33% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • January 2026: 50.00% Strong Buy, 50.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is InspireMD’s EPS forecast?

InspireMD's average annual EPS forecast for its fiscal year ending in December 2026 is $-1.25, marking a 64.47% increase from the reported $-0.76 in 2025. Estimates for the following years are.

What is InspireMD’s revenue forecast?

InspireMD's average annual revenue forecast for its fiscal year ending in December 2026 is $26.78M, reflecting a 198.30% increase from the reported $8.98M in 2025. The forecast for.

What is InspireMD’s net income forecast?

InspireMD's net income forecast for the fiscal year ending in December 2026 stands at $-30.214M, representing a -3491.01% decrease from the reported $891K in 2025. Projections indicate .